Literature DB >> 8045264

A novel set of spliceosome-associated proteins and the essential splicing factor PSF bind stably to pre-mRNA prior to catalytic step II of the splicing reaction.

O Gozani1, J G Patton, R Reed.   

Abstract

We have isolated and determined the protein composition of the spliceosomal complex C. The pre-mRNA in this complex has undergone catalytic step I, but not step II, of the splicing reaction. We show that a novel set of 14 spliceosome-associated proteins (SAPs) and the essential splicing factor PSF are specifically associated with the C complex, implicating these proteins in catalytic step II. Significantly, immunodepletion and biochemical complementation studies demonstrate directly that PSF is essential for catalytic step II. Purified PSF is known to UV crosslink to pyrimidine tracts, and our data show that PSF UV crosslinks to pre-mRNA in purified C complex. Thus, PSF may replace the 3' splice site binding factor U2AF65 which is destabilized during spliceosome assembly. Finally, we show that SAPs 60 and 90, which are present in both the B and C complexes, are specifically associated with U4 and U6 snRNPs, and thus may have important roles in the functioning of these snRNPs during the splicing reaction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8045264      PMCID: PMC395233          DOI: 10.1002/j.1460-2075.1994.tb06638.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  73 in total

1.  Domains of yeast U4 spliceosomal RNA required for PRP4 protein binding, snRNP-snRNP interactions, and pre-mRNA splicing in vivo.

Authors:  R Bordonné; J Banroques; J Abelson; C Guthrie
Journal:  Genes Dev       Date:  1990-07       Impact factor: 11.361

2.  Protein composition of mammalian spliceosomes assembled in vitro.

Authors:  R Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

3.  A mutational analysis of spliceosome assembly: evidence for splice site collaboration during spliceosome formation.

Authors:  A I Lamond; M M Konarska; P A Sharp
Journal:  Genes Dev       Date:  1987-08       Impact factor: 11.361

4.  Interactions between small nuclear ribonucleoprotein particles in formation of spliceosomes.

Authors:  M M Konarska; P A Sharp
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

5.  Electrophoretic separation of complexes involved in the splicing of precursors to mRNAs.

Authors:  M M Konarska; P A Sharp
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

6.  A protein associated with small nuclear ribonucleoprotein particles recognizes the 3' splice site of premessenger RNA.

Authors:  V Gerke; J A Steitz
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

7.  Electrophoresis of ribonucleoproteins reveals an ordered assembly pathway of yeast splicing complexes.

Authors:  C W Pikielny; B C Rymond; M Rosbash
Journal:  Nature       Date:  1986 Nov 27-Dec 3       Impact factor: 49.962

8.  The yeast PRP6 gene encodes a U4/U6 small nuclear ribonucleoprotein particle (snRNP) protein, and the PRP9 gene encodes a protein required for U2 snRNP binding.

Authors:  N Abovich; P Legrain; M Rosbash
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

9.  A trans-acting suppressor restores splicing of a yeast intron with a branch point mutation.

Authors:  J R Couto; J Tamm; R Parker; C Guthrie
Journal:  Genes Dev       Date:  1987-07       Impact factor: 11.361

10.  A protein that specifically recognizes the 3' splice site of mammalian pre-mRNA introns is associated with a small nuclear ribonucleoprotein.

Authors:  J Tazi; C Alibert; J Temsamani; I Reveillaud; G Cathala; C Brunel; P Jeanteur
Journal:  Cell       Date:  1986-12-05       Impact factor: 41.582

View more
  110 in total

1.  Resolution of the mammalian E complex and the ATP-dependent spliceosomal complexes on native agarose mini-gels.

Authors:  R Das; R Reed
Journal:  RNA       Date:  1999-11       Impact factor: 4.942

2.  An exonic splicing silencer in the testes-specific DNA ligase III beta exon.

Authors:  S L Chew; L Baginsky; I C Eperon
Journal:  Nucleic Acids Res       Date:  2000-01-15       Impact factor: 16.971

3.  The 100-kda U5 snRNP protein (hPrp28p) contacts the 5' splice site through its ATPase site.

Authors:  N Ismaïli; M Sha; E H Gustafson; M M Konarska
Journal:  RNA       Date:  2001-02       Impact factor: 4.942

4.  An upstream AG determines whether a downstream AG is selected during catalytic step II of splicing.

Authors:  K Chua; R Reed
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

5.  Role of the 3' splice site in U12-dependent intron splicing.

Authors:  R C Dietrich; M J Peris; A S Seyboldt; R A Padgett
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

6.  The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions.

Authors:  H Le Hir; E Izaurralde; L E Maquat; M J Moore
Journal:  EMBO J       Date:  2000-12-15       Impact factor: 11.598

7.  Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry.

Authors:  P Ajuh; B Kuster; K Panov; J C Zomerdijk; M Mann; A I Lamond
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

8.  Domains in human splicing factors SF3a60 and SF3a66 required for binding to SF3a120, assembly of the 17S U2 snRNP, and prespliceosome formation.

Authors:  D Nesic; A Krämer
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

9.  Pseudoexon activation as a novel mechanism for disease resulting in atypical growth-hormone insensitivity.

Authors:  L A Metherell; S A Akker; P B Munroe; S J Rose; M Caulfield; M O Savage; S L Chew; A J Clark
Journal:  Am J Hum Genet       Date:  2001-07-20       Impact factor: 11.025

10.  Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis.

Authors:  Melissa S Jurica; Lawrence J Licklider; Steven R Gygi; Nikolaus Grigorieff; Melissa J Moore
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.